We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

19 hedge funds and large institutions have $5.98M invested in ImmuCell in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital invested

Capital invested by funds: $4.34M → $5.98M (+$1.65M)

27% more funds holding

Funds holding: 15 → 19 (+4)

0.77% less ownership

Funds ownership: 13.22% → 12.45% (-0.77%)

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
8
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PCM
Perritt Capital Management
Illinois
+$168K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$136K
3
RC
RBF Capital
California
+$107K
4
EIM
Essex Investment Management
Massachusetts
+$69.5K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$11.2K

Top Sellers

Rank Fund Capital Flow
1
HA
Heartland Advisors
Wisconsin
-$208K
2
Deutsche Bank
Deutsche Bank
Germany
-$54K
3
Morgan Stanley
Morgan Stanley
New York
-$52.4K
4
Renaissance Technologies
Renaissance Technologies
New York
-$35.2K
5
Wells Fargo
Wells Fargo
California
-$13.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$1.75M -$208K -25,400 -11%
PCM
2
Perritt Capital Management
Illinois
$1.36M +$168K +20,500 +15%
Renaissance Technologies
3
Renaissance Technologies
New York
$825K -$35.2K -4,300 -4%
SRC
4
Shufro Rose & Co
New York
$429K -$8.18K -1,000 -2%
EIM
5
Essex Investment Management
Massachusetts
$309K +$69.5K +8,494 +32%
Vanguard Group
6
Vanguard Group
Pennsylvania
$289K +$2.45K +300 +0.9%
EFS
7
Essex Financial Services
Connecticut
$209K – – –
Wells Fargo
8
Wells Fargo
California
$202K -$13.9K -1,701 -7%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$146K +$136K +16,600 New
MA
10
Minerva Advisors
Pennsylvania
$119K – – –
Morgan Stanley
11
Morgan Stanley
New York
$115K -$52.4K -6,408 -33%
RC
12
RBF Capital
California
$115K +$107K +13,086 New
Deutsche Bank
13
Deutsche Bank
Germany
$46K -$54K -6,600 -55%
UBS Group
14
UBS Group
Switzerland
$35K – – –
Bank of America
15
Bank of America
North Carolina
$17K -$123 -15 -0.7%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$12K +$11.2K +1,372 New
BlackRock
17
BlackRock
New York
$6K – – –
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– -$4.09K -500 -100%
TRCT
19
Tower Research Capital (TRC)
New York
– +$434 +53 New

ICCC Hedge Fund Activity: Q4 2017 in Review

19 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2017, worth a combined $5.98M — up 38% from $4.34M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ICCC positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 8 trimmed.

The largest buyer was Perritt Capital Management, adding an estimated $168K. The largest seller was Heartland Advisors, cutting an estimated $208K.

  • 19 institutional investors held ImmuCell (ICCC) as of Q4 2017, up from 15 in Q3 2017.
  • Funds reported $5.98M of ImmuCell stock for Q4 2017, up 38% quarter-over-quarter.
  • 4 funds opened new ImmuCell positions in Q4 2017 and 0 closed out, a net change of +4 holders.
  • The largest ImmuCell buyer in Q4 2017 was Perritt Capital Management, an estimated $168K added.
  • The largest ImmuCell seller in Q4 2017 was Heartland Advisors, an estimated $208K sold.

Based on aggregated 13F filings for Q4 2017.